Seeking Alpha

Galena Biopharma (GALE) +21.9% premarket after receiving a Notice of Allowance from the U.S....

Galena Biopharma (GALE) +21.9% premarket after receiving a Notice of Allowance from the U.S. patent office for a patent covering the use of its NeuVax product candidate, a vaccine for inducing immunity to breast cancer recurrence in some patients. (PR)
From other sites
Comments (0)
Be the first to comment
DJIA (DIA) S&P 500 (SPY)
ETF Tools
Find the right ETFs for your portfolio:
Seeking Alpha's new ETF Hub
ETF Investment Guide:
Table of Contents | One Page Summary
Read about different ETF Asset Classes:
ETF Selector